NDC product
Asthma Therapy
NDC 17312-017 · TRP Company
Key facts
| Product NDC | 17312-017 |
|---|---|
| Proprietary name | Asthma Therapy |
| Nonproprietary name | ARSENIC TRIOXIDE - HISTAMINE DIHYDROCHLORIDE - DERMATOPHAGOIDES PTERONYSSINUS - MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE - STRYCHNOS NUX-VOMICA SEED - ASPIDOSPERMA QUEBRACHO-BLANCO BARK - SUPLHUR - |
| Substances | STRYCHNOS NUX-VOMICA SEED, ASPIDOSPERMA QUEBRACHO-BLANCO BARK, SULFUR, ARSENIC TRIOXIDE, HISTAMINE DIHYDROCHLORIDE, DERMATOPHAGOIDES PTERONYSSINUS, MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE |
| Dosage form | TABLET, ORALLY DISINTEGRATING |
| Route | ORAL |
| Labeler | TRP Company |
| Product type | HUMAN OTC DRUG |
| Marketing category | UNAPPROVED HOMEOPATHIC |
| Pharmacologic classes | Allergens [CS], Antigens, Dermatophagoides [CS], Calculi Dissolution Agent [EPC], Cell-mediated Immunity [PE], Increased Histamine Release [PE] and 13 more |
| Marketing start | Dec 1, 2011 |
| Listing certified through | Dec 31, 2026 |
At a glance
- 1–9 Package NDCs
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About National Drug Codes (NDC)
The National Drug Code (NDC) is the FDA's product identifier for drugs; the product NDC identifies the labeler and product, and each package adds a package code.
Source: U.S. Food and Drug Administration (FDA), National Drug Code Directory · Source date: